Valsartan is a selective angiotensin II AT1 receptor antagonist with elimination half-life of 6 hours.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | Valsartan is a blocker in angiotensin II receptor used in the treatment of hypertension and congestive heart failure, with IC50 ranging from 39.5 to116 uM. In vitro,Valsartan (50 μM) induced a significant increase in p-AMPK and p-LKB1.Valsartan inhibited NF - κ B activity and significantly reduced the expression and activity of inflammatory cytokines, TLR-4, TF induced by Hg[3]. The main antihypertensive effect of valsartan is mediated by a reduction in angiotensin II activation of the AT1-R in vascular smooth muscle. The peak plasma concentration (C max) of valsartan occurs within 2-4 h after dosing, and absolute bioavailability is roughly 25%[4]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00190580 | Chronic Kidney Disease ... 展开 >> Hypertension 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> St. Marianna University School of Medicine Kawasaki, Kanagawa, Japan, 216-8511 收起 << |
NCT00386607 | Hypertension | Phase 3 | Completed | - | United States, California ... 展开 >> Investigative Centers San Diego, California, United States Canada Investigative Centers Canada, Canada Germany Investigative Centers Germany, Germany Netherlands Investigative Centers Netherlands, Netherlands 收起 << |
NCT00386607 | - | Completed | - | - | |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.30mL 0.46mL 0.23mL |
11.48mL 2.30mL 1.15mL |
22.96mL 4.59mL 2.30mL |
CAS号 | 137862-53-4 |
分子式 | C24H29N5O3 |
分子量 | 435.52 |
别名 | CGP 48933 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,Room Temperature |
溶解度 |
DMSO: 50 mg/mL(114.81 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |
Tags: Valsartan | CGP 48933 | Cardiovascular System | Drug Standard | Depressurization | Angiotensin Receptor | AmBeed-信号通路专用抑制剂 | Valsartan 纯度/质量文件 | Valsartan 生物活性 | Valsartan 临床数据 | Valsartan 参考文献 | Valsartan 实验方案 | Valsartan 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
AT2 receptor |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00190580 | Chronic Kidney Disease ... 展开 >> Hypertension 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> St. Marianna University School of Medicine Kawasaki, Kanagawa, Japan, 216-8511 收起 << |
NCT00386607 | Hypertension | Phase 3 | Completed | - | United States, California ... 展开 >> Investigative Centers San Diego, California, United States Canada Investigative Centers Canada, Canada Germany Investigative Centers Germany, Germany Netherlands Investigative Centers Netherlands, Netherlands 收起 << |
NCT00386607 | - | Completed | - | - | |
NCT01406431 | Hyperlipidemia ... 展开 >> Hypertension 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of 收起 << |
NCT01129557 | Proteinuric Kidney Disease ... 展开 >> Diabetic Nephropathy Hypertensive Nephrosclerosis IgA Nephropathy Focal Segmental Glomerulosclerosis Glomerulopathy (Obesity-associated) Glomerulonephritis, Membranous 收起 << | Phase 4 | Terminated | - | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT02415192 | - | Unknown | November 2016 | Korea, Republic of ... 展开 >> LG Life Science Recruiting Seoul, Jongno gu, Korea, Republic of, 110-783 Contact: Hye jin Yoon 收起 << | |
NCT01129557 | - | Terminated | - | - | |
NCT03279861 | Congestive Heart Failure ... 展开 >> Hypertension 收起 << | Phase 4 | Withdrawn(protocol change) | November 2019 | - |
NCT00277472 | Hypertension | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> Novartis East Hanover, New Jersey, United States, 07936 收起 << |
NCT00687206 | Hypertension ... 展开 >>Ventricular Remodeling Erectile Dysfunctions 收起 << | Phase 4 | Completed | - | Italy ... 展开 >> Department of internal medicine University Federico II Naples, Italy, 80131 收起 << |
NCT00367939 | Hypertension | Phase 3 | Completed | - | Germany ... 展开 >> Investigative Centers, Germany 收起 << |
NCT00523549 | Hypertension ... 展开 >>Diastolic Dysfunction 收起 << | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> Novartis Investigative Sites USA, New Jersey, United States 收起 << |
NCT00523549 | - | Completed | - | - | |
NCT02970669 | Heart Failure, Reduced Ejectio... 展开 >>n Fraction 收起 << | Phase 4 | Completed | - | United States, Alabama ... 展开 >> Novartis Investigative Site Fort Payne, Alabama, United States, 35967 United States, California Novartis Investigative Site Beverly Hills, California, United States, 90211 Novartis Investigative Site Stockton, California, United States, 95204 Novartis Investigative Site West Hills, California, United States, 91307 United States, Florida Novartis Investigative Site Doral, Florida, United States, 33126 Novartis Investigative Site Inverness, Florida, United States, 34452 Novartis Investigative Site Ormond Beach, Florida, United States, 32174 Novartis Investigative Site Port Orange, Florida, United States, 32127 United States, Maryland Novartis Investigative Site Lutherville, Maryland, United States, 21093 United States, New Jersey Novartis Investigative Site East Brunswick, New Jersey, United States, 08816 Novartis Investigative Site Ridgewood, New Jersey, United States, 07450 United States, South Carolina Novartis Investigative Site Columbia, South Carolina, United States, 29203 Novartis Investigative Site Greenville, South Carolina, United States, 29615 Novartis Investigative Site Lancaster, South Carolina, United States, 29720 United States, Texas Novartis Investigative Site Allen, Texas, United States, 75002-3688 Novartis Investigative Site McKinney, Texas, United States, 75013 Novartis Investigative Site New Braunfels, Texas, United States, 78130 Novartis Investigative Site San Antonio, Texas, United States, 78229 Novartis Investigative Site San Marcos, Texas, United States, 78666 Novartis Investigative Site Sherman, Texas, United States, 75092 Novartis Investigative Site Tomball, Texas, United States, 77375 United States, Virginia Novartis Investigative Site Midlothian, Virginia, United States, 23114 United States, Washington Novartis Investigative Site Tacoma, Washington, United States, 98405 收起 << |
NCT01415505 | Hypertension | Phase 3 | Completed | - | - |
NCT00523744 | Hypertension | Phase 3 | Completed | - | Germany ... 展开 >> Novartis Investigative Site, , Germany Schwerin, Germany 收起 << |
NCT00698646 | Hypertension | Phase 4 | Completed | - | United States, Alabama ... 展开 >> Investigative site Birmingham, Alabama, United States United States, Arizona Investigative site Phoenix, Arizona, United States United States, California Investigative Site Escondido, California, United States Investigative site Fresno, California, United States Investigative site Huntington Park, California, United States Investigative Sites Pismo Beach, California, United States United States, Florida Investigative site Miami, Florida, United States Investigative site Ormond Beach, Florida, United States United States, Georgia Investigative site Conyers, Georgia, United States United States, Kentucky Investigative Site Lexington, Kentucky, United States United States, Maine Investigative site Portland, Maine, United States United States, Nevada Investigative site Las Vegas, Nevada, United States United States, New York Investigative site Buffalo, New York, United States United States, North Carolina Investigative site Shelby, North Carolina, United States United States, Ohio Investigative site Carlisle, Ohio, United States United States, Oklahoma Investigative site Oklahoma City, Oklahoma, United States United States, Pennsylvania Investigative site Erie, Pennsylvania, United States United States, South Carolina Investigative Site Greer, South Carolina, United States Investigative Site Taylors, South Carolina, United States United States, Utah Investigative site St George, Utah, United States 收起 << |
NCT00523744 | - | Completed | - | - | |
NCT00698646 | - | Completed | - | - | |
NCT02069821 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Chungnam national university hospital Daejeon, Jung-gu, Korea, Republic of, 301-721 收起 << |
NCT00874601 | Acute Ischemic Stroke | Phase 4 | Unknown | July 2012 | Korea, Republic of ... 展开 >> Hallym University Sacred Heart Hospital Recruiting Anyang, Gyeonggi, Korea, Republic of, 430-070 Contact: Byung-chul Lee, MD, PhD +82-31-380-3741 ssbrain@hallym.ac.kr Sub-Investigator: Kyung-ho Yu, MD, PhD 收起 << |
NCT02519010 | Healthy | Phase 1 | Completed | - | Egypt ... 展开 >> Genuine Research Center GRC Cairo, Egypt 收起 << |
NCT00550095 | Microalbuminuria ... 展开 >> Proteinuria 收起 << | Phase 4 | Completed | - | Egypt ... 展开 >> Novartis Investigative Site , Cairo, Egypt 收起 << |
NCT00439738 | Hypertension | Phase 4 | Completed | - | United States, Alabama ... 展开 >> Terence T. Hart, MD Muscle Shoals, Alabama, United States, 35662 United States, California Westlake Medical Research Westlake Village, California, United States, 91361 United States, Oklahoma Oklahoma Cardiovascular & Hypertension Oklahoma City, Oklahoma, United States, 73132 United States, Texas Northeast Tarrant Internal Medicine Assoc Euless, Texas, United States, 76040 United States, Washington Frandsen Family Medicine Port Orchard, Washington, United States, 98366 收起 << |
NCT00439738 | - | Completed | - | - | |
NCT02403349 | Blood Pressure ... 展开 >> Ischemic Stroke 收起 << | Phase 4 | Unknown | September 2015 | - |
NCT00425997 | Hypertension | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> Sites in USA East Hanover, New Jersey, United States, 07936 收起 << |
NCT03771729 | CKD | Early Phase 1 | Not yet recruiting | June 15, 2019 | - |
NCT00939588 | Hypertension | Phase 2 | Completed | - | Russian Federation ... 展开 >> Novartis Investigative Site Moscow, Russian Federation 收起 << |
NCT00413049 | Hypertension | Phase 3 | Completed | - | China ... 展开 >> China-Japan Friendship Hospital Beijing, China, 100029 People's hospital affiliated Beijing University Beijing, China, 100044 The third Xiangya hospital of central south University Changsha, China, 410003 The first hospital affiliated the third military Medical University Chongqing, China, 400038 The third hospital affiliated the third military Medical University Chongqing, China, 400042 Union hospital affiliated Fujian medical University Fuzhou, China, 350001 The first hospital affiliated Fujian medical University Fuzhou, China, 350005 The second hospital affiliated Jiangxi medical school Nanchang, China, 330006 Institute of Hypertension, Ruijin Hospital Shanghai, China, 200025 Zhongshan hospital affiliated Fudan University Shanghai, China, 200032 The sixth people's hospital of Shanghai Shanghai, China, 200233 The first hospital affiliated school of medical of Xi'an Jiaotong University Xi'an, China, 710061 收起 << |
NCT00413413 | Hypertension | Phase 3 | Completed | - | China ... 展开 >> Beijing ChaoYang Hospital, Affiliate of Capital University of Medical Sciences Beijing, China, 100020 Beijing General Hospital of Beijing Military Region Beijing, China, 100700 Beijing Hospital Beijing, China, 100730 The First People's Hospital of Hangzhou Hangzhou, China, 310006 The Second Affiliated Hospital of Medical College of Zhejiang University Hangzhou, China, 310006 The First Affiliated Hospital of Medical College of Zhejiang University Hangzhou, China, 310007 Southeast University Affiliated Zhong Da Hospital Nanjing, China, 210009 The First Affiliated Hospital of Nanjing Medical University Nanjing, China, 210029 Second Military Medical University Affiliated Changzheng Hospital Shanghai, China, 200003 Department of cardiology, Ruijin hospital; Shanghai, China, 200025 Department of cardiology, Ruijin hospital Shanghai, China, 200025 Fudan University affiliated zhongshan hospital Shanghai, China, 200032 Second Military Medical University Affiliated Changhai Hospital Shanghai, China, 200433 The First Affiliated Hospital of China Medical University Shenyang, China, 110001 The people's Hospital of Liaoning Province Shenyang, China, 110016 Second Hospital of Hebei University of Medical Sciences Shijiazhuang, China, 050050 The People's Hospital of Hebei Provincial Shijiazhuang, China, 050051 The Second Affiliated Hospital of Soochow University Suzhou, China, 215004 The First Affiliated Hospital of Soochow University Suzhou, China, 215006 收起 << |
NCT00413413 | - | Completed | - | - | |
NCT00413049 | - | Completed | - | - | |
NCT00302705 | Hypertension | Phase 4 | Completed | - | Spain ... 展开 >> Hospital Clínico Universitario de Santiago Santiago de Compostela, Spain, 15706 收起 << |
NCT01122251 | Essential Hypertension | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> 23 sites in Korea Seoul, Busan etc., Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT00394745 | Hypertension ... 展开 >>Metabolic Syndrome 收起 << | Phase 3 | Completed | - | Germany ... 展开 >> Investigative Centers, Germany Switzerland Novartis Basel, Switzerland 收起 << |
NCT01167153 | - | Completed | - | - | |
NCT02900378 | Chronic Heart Failure With Red... 展开 >>uced Ejection Fraction 收起 << | Phase 3 | Completed | - | - |
NCT01375322 | Hypertension ... 展开 >>Diabetes Mellitus, Type 2 Albuminuria 收起 << | Phase 4 | Completed | - | Taiwan ... 展开 >> Chang Gung Memorial Hospital-Kaohsiung Kaohsiung, Taiwan, 833 Taichung Veterans General Hospital Taichung, Taiwan, 407 Tri-Service General Hospital Taipei, Taiwan, 114 Far Eastern Memorial Hospital Taipei, Taiwan, 220 收起 << |
NCT01167153 | Hypertension | Phase 4 | Completed | - | China ... 展开 >> Novartis Pharmaceuticals Beijing, China 收起 << |
NCT02973035 | Hypertension | Phase 4 | Recruiting | June 2019 | Korea, Republic of ... 展开 >> Busan Baik Hospital Recruiting Busan, Korea, Republic of Contact: Jeong-Suk Seo, M.D. orifilter@hanmail.net Busan University Hospital Recruiting Busan, Korea, Republic of Contact: Yong-Hyun Park nadroj@chol.com Chungnam University Hospital Recruiting Daejeon, Korea, Republic of Contact: Jae-Hyung Park, M.D. jaehpark@cnuh.co.kr Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Duk-Hyun Kang, M.D. dhkang@amc.seoul.kr 收起 << |
NCT01365481 | - | Completed | - | - | |
NCT01447485 | Hypertension ... 展开 >>Chronic Kidney Disease Nephrotic Syndrome 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> Novartis Investigative Site Aichi, Japan Novartis Investigative Site Tokyo, Japan 收起 << |
NCT01735890 | Healthy | Phase 1 | Completed | - | - |
NCT01365481 | Hypertension ... 展开 >>Chronic Kidney Disease 收起 << | Phase 3 | Completed | - | Colombia ... 展开 >> Novartis Investigative Site Bucaramanga, Santander, Colombia, 0001 Novartis Investigative Site Barranquilla, Colombia Novartis Investigative Site Cali, Colombia Finland Novartis Investigative Site Helsinki, Finland, 00029 Germany Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Cottbus, Germany, 03048 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Rostock, Germany, 18107 Guatemala Novartis Investigative Site Guatemala City, Guatemala, 01010 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Philippines Novartis Investigative Site Manila, Philippines, 1000 Novartis Investigative Site Quezon City, Philippines, 1100 Novartis Investigative Site Quezon City, Philippines, 1101 Poland Novartis Investigative Site Warszawa, Poland, 04-154 Romania Novartis Investigative Site Cluj-Napoca, Jud Cluj, Romania Novartis Investigative Site Tg. Mures, jud Mures, Romania, 540104 Novartis Investigative Site Timisoara, jud. Timis, Romania, 300011 Novartis Investigative Site Bucuresti, Romania, 041451 Novartis Investigative Site Bucuresti, Romania, 20395 Novartis Investigative Site Iasi, Romania, 700309 Russian Federation Novartis Investigative Site Kazan, Russian Federation, 420012 Novartis Investigative Site Moscow, Russian Federation, 119991 Novartis Investigative Site Moscow, Russian Federation, 125315 Novartis Investigative Site Moscow, Russian Federation, 127412 Novartis Investigative Site Voronezh, Russian Federation, 394036 Singapore Novartis Investigative Site Singapore, Singapore, 119074 Novartis Investigative Site Singapore, Singapore, 229899 收起 << |
NCT00589732 | Coronary Artery Disease | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Samsung Medical Center Seoul, Korea, Republic of St. Mary's Catholic Medical Center Seoul, Korea, Republic of Yonsei University Medical Center Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of 收起 << |
NCT00927394 | Hypertension | Phase 4 | Completed | - | United States, Delaware ... 展开 >> Investigative Site Newark, Delaware, United States, USA United States, Missouri Investigative Site Kansas, Missouri, United States United States, New Jersey Investigative Site Camden, New Jersey, United States United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States 收起 << |
NCT00927394 | - | Completed | - | - | |
NCT00415883 | Healthy | Phase 1 | Completed | - | India ... 展开 >> Novartis Investigative Site Mumbai, India 收起 << |
NCT01432106 | Hypertension ... 展开 >>Metabolic Syndrome 收起 << | Phase 1 | Withdrawn(Novartis terminated ... 展开 >>all projects involving aliskiren. Findings of the DMC overseeing the ALTITUDE clinical trial found a higher incidence of adverse events.) 收起 << | - | United States, Michigan ... 展开 >> University of Michigan Health System Ann Arbor, Michigan, United States, 48106 收起 << |
NCT02554890 | Acute Heart Failure | Phase 4 | Completed | - | - |
NCT00790946 | Hypertension ... 展开 >>Obesity 收起 << | Phase 4 | Unknown | December 2009 | Japan ... 展开 >> Chuwa Tei,MD,FACC,FAHA Recruiting Kagoshima, Japan, 890-8520 Contact: Chuwa Tei, MD,FACC,FAHA tei@m.kufm.kagoshima-u.ac.jp Contact: Masaaki Miyata, MD,PhD、FACC miyatam@m3.kufm.kagoshima-u.ac.jp 收起 << |
NCT01617681 | Pediatric Hypertension With or... 展开 >> Without CKD 收起 << | Phase 3 | Completed | - | Belgium ... 展开 >> Novartis Investigative Site Antwerpen, Belgium, 2020 Novartis Investigative Site Liege, Belgium, 4000 Brazil Novartis Investigative Site Curitibia, Parana, Brazil, 80250-060 Novartis Investigative Site Campinas, Brazil, 13087-567 Novartis Investigative Site Caxias do Sul, Brazil, 95070-561 Novartis Investigative Site Porto Alegre, Brazil, 90610-000 France Novartis Investigative Site Montpellier, France, 34059 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Marburg, Germany, 35039 Guatemala Novartis Investigative Site Guatemala City, Guatemala, 01010 Novartis Investigative Site Guatemala, Guatemala, 01001 Novartis Investigative Site Guatemala, Guatemala, 1010 Hungary Novartis Investigative Site Budapest, Hungary, H 1096 Novartis Investigative Site Budapest, Hungary, H-1083 Novartis Investigative Site Szeged, Hungary, 6725 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site San Donato Milanese, MI, Italy, 20097 Novartis Investigative Site Palermo, Italy, 90134 Lithuania Novartis Investigative Site Vinius, Lithuania, 08406 Poland Novartis Investigative Site Bialystok, Poland, 15-274 Novartis Investigative Site Gdansk, Poland, 80-952 Novartis Investigative Site Krakow, Poland, 30-663 Novartis Investigative Site Lodz, Poland, 93-338 Novartis Investigative Site Lublin, Poland, 20-093 Novartis Investigative Site Poznan, Poland, 61-825 Novartis Investigative Site Szczecin, Poland, 71-252 Novartis Investigative Site Warszawa, Poland, 04-154 收起 << |
NCT01617681 | - | Completed | - | - | |
NCT00416468 | Healthy | Phase 1 | Completed | - | United States, New Jersey ... 展开 >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 收起 << |
NCT02343250 | Hypertension | Phase 1 | Completed | - | - |
NCT00416728 | Healthy | Phase 1 | Completed | - | United States, New Jersey ... 展开 >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 收起 << |
NCT01767259 | Healthy Normotensive Participa... 展开 >>nts 收起 << | Not Applicable | Completed | - | Egypt ... 展开 >> Pharmaceutics Department, Faculty of Pharmacy, Damanhour University Damanhour, Egypt 收起 << |
NCT02788656 | Congestive Heart Failure | Not Applicable | Recruiting | March 2019 | United States, Massachusetts ... 展开 >> Brigham and Women's Hospita Recruiting Boston, Massachusetts, United States, 02115 Contact: Lynne Stevenson, MD 617-732-5500 lstevenson@partners.org Contact: Akshay Desai, MD 917-732-5500 adesai@partners.org 收起 << |
NCT02088008 | Healthy Volunteers | Phase 1 | Unknown | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Kyungsang Yu Principal Investigator: Kyungsang Yu 收起 << |
NCT01878201 | Essential Hypertension | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT02884206 | Chronic Heart Failure (CHF) | Phase 3 | Recruiting | May 23, 2022 | - |
NCT00858299 | Chronic Kidney Disease ... 展开 >> Proteinuria 收起 << | Phase 4 | Unknown | December 2011 | Korea, Republic of ... 展开 >> Division of Nephrology, Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of, 135-710 Principal Investigator: Yoon-Goo Kim, Professor 收起 << |
NCT01918332 | Hypertension, ... 展开 >> Hyperlipidemia 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Yonsei University Health System Severance Hospital Seoul, Korea, Republic of 收起 << |
NCT01241487 | Primary Hypertension | Phase 4 | Completed | - | Egypt ... 展开 >> Dr Ahmed Anwar Clinic, Cairo, Egypt 收起 << |
NCT00745953 | Metabolic Syndrome ... 展开 >> Lipotoxicity 收起 << | Phase 4 | Unknown | August 2009 | United States, Texas ... 展开 >> University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 收起 << |
NCT00457626 | Hypertension | Phase 3 | Completed | - | - |
NCT01918332 | - | Completed | - | - | |
NCT02058446 | Essential Hypertension | Phase 4 | Completed | - | Taiwan ... 展开 >> Taichung Veterans General Hospital Taichung, Taiwan, 40705 收起 << |
NCT03553303 | Heart Failure, Systolic | Phase 4 | Recruiting | May 2022 | Norway ... 展开 >> Ringerike Hospital Vestre Viken Hospital Trust Recruiting Hønefoss, Buskerud, Norway, 3511 Contact: Christian Hall +4747500900 Contact: Hall 收起 << |
NCT00140790 | Hypertension | Phase 4 | Terminated(The number of actua... 展开 >>l events was extremely low. We extended the study period, but it was still not enough. Also, many patients were loss of follow up.) 收起 << | - | Japan ... 展开 >> Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto, Japan, 860-8556 Department of Cardiovascular Medicine, Kumamoto University Hospital Kumamoto, Japan, 860-8556 收起 << |
NCT01402843 | Hypertension ... 展开 >>Dyslipidemia 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Chungbuk National University Hospital Chung Ju, Korea, Republic of Konyang University Hospital Daejeon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Hallym University Medical Center Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of Ajou University Medical Center Suwon, Korea, Republic of 收起 << |
NCT03476616 | Hypertension ... 展开 >>Obesity 收起 << | Phase 4 | Not yet recruiting | September 1, 2020 | Greece ... 展开 >> Hypertension Unit, First Cardiology Clinic, Hippocration General Hospital, University of Athens, Athens, Greece Not yet recruiting Athens, Greece, 11527 Contact: Konstantinos P Tsioufis, Ass. Prof. 6932586087 ext +30 ktsioufis@hippocratio.gr Contact: Panayiotis P Iliakis, MD 6937489286 ext +30 panayiotisiliakis@gmail.com Principal Investigator: Konstantinos P Tsioufis, Ass. Prof. Sub-Investigator: Kyriakos S Dimitriadis, MD, PhD Sub-Investigator: Panayiotis P Iliakis, MD 收起 << |
NCT01767298 | Healthy Normotensive Participa... 展开 >>nts 收起 << | Not Applicable | Completed | - | - |
NCT00208767 | Carotid Artery Diseases ... 展开 >> Atherosclerosis 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Emory University School of Medicine Atlanta, Georgia, United States, 30322 收起 << |
NCT02299310 | Chronic Kidney Disease | Phase 4 | Unknown | December 2015 | China, Beijing ... 展开 >> Chinese PLA General Hospital Beijing, Beijing, China, 100853 收起 << |
NCT02480764 | Essential Hypertension | Phase 3 | Completed | - | - |
NCT03387163 | - | Recruiting | June 17, 2019 | United States, New York ... 展开 >> Novartis Investigative Site Recruiting New York, New York, United States, 10029 收起 << | |
NCT01001572 | - | Completed | - | - | |
NCT01764178 | Hyperlipidemia ... 展开 >> Hypertension 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 << |
NCT00149227 | Hypertension ... 展开 >>Ischemic Heart Disease Congestive Heart Failure Stroke 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 收起 << |
NCT00149227 | - | Completed | - | - | |
NCT01095822 | Diabetes Mellitus | Phase 4 | Unknown | March 2011 | United States, Maryland ... 展开 >> Dr. Pokov's Polyclinic. 6821 Reisterstown Road Suite 206 Baltimore, Maryland, United States, 21215 收起 << |
NCT00208767 | - | Completed | - | - | |
NCT02662894 | Hypertension ... 展开 >>Dyslipidemia 收起 << | Phase 3 | Not yet recruiting | December 2020 | - |
NCT02197442 | Healthy | Not Applicable | Completed | - | India ... 展开 >> Lambda Therapeutic Research Ltd., Ahmedabad, Gujarat, India, 380 061 收起 << |
NCT01001572 | Essential Hypertension | Phase 3 | Completed | - | - |
NCT02197494 | Healthy | Not Applicable | Completed | - | India ... 展开 >> Lambda Therapeutic Research Ltd. Navi Mumbai, Maharashtra, India, 400 614 收起 << |
NCT00931710 | Stage 2 Systolic Hypertension | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> sites in USA East Hanover, New Jersey, United States 收起 << |
NCT03552575 | Heart Failure | Phase 3 | Not yet recruiting | August 31, 2020 | - |
NCT01920711 | Heart Failure With Preserved E... 展开 >>jection Fraction 收起 << | Phase 3 | Active, not recruiting | May 31, 2019 | - |
NCT03300427 | Heart Failure | Phase 4 | Recruiting | September 2, 2019 | Finland ... 展开 >> Novartis Investigative Site Recruiting Turku, Finland 收起 << |
NCT02817217 | Type 2 Diabetes | Phase 1 | Unknown | - | China, Sichuan ... 展开 >> People's Liberation Army General Hospital of Chengdu Military Region Recruiting Chengdu, Sichuan, China Contact: Xiaolan Yong, docter 028-86571275 Yongxiaolan@126.com 收起 << |
NCT01070043 | - | Completed | - | - | |
NCT01070043 | Hypertension ... 展开 >>High Blood Pressure 收起 << | Phase 4 | Completed | - | Taiwan ... 展开 >> Taipei, Taiwan, 11217 收起 << |
NCT00809926 | Stage 2 Hypertension | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> Sites in USA East Hanover, New Jersey, United States, 07936 收起 << |
NCT02887183 | Heart Failure | Phase 4 | Recruiting | October 18, 2018 | - |
NCT01681576 | Salt-sensitive Hypertension | Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Anaheim, California, United States, 92801 Novartis Investigative Site Cypress, California, United States, 90630 Novartis Investigative Site Glendale, California, United States, 91206 Hong Kong Novartis Investigative Site Hong Kong, Shatin, NT, Hong Kong Korea, Republic of Novartis Investigative Site Bucheon, Gyeonggi-do, Korea, Republic of, 424-717 Novartis Investigative Site Koyang-si, Gyeonggi-do, Korea, Republic of, 410-773 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Republic of, 120-752 Novartis Investigative Site Seoul, Korea, Republic of, 152-703 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Novartis Investigative Site Singapore, Singapore, 169609 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Taichung, Taiwan, 40447 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 114 收起 << |
NCT00809926 | - | Completed | - | - | |
NCT01541189 | Hypertension | Phase 4 | Completed | - | China, Beijing ... 展开 >> Novartis Investigative Site Beijing, Beijing, China, 100044 收起 << |
NCT01681576 | - | Completed | - | - | |
NCT01805804 | First Time Dual Chamber Pacema... 展开 >>ker Implantation 收起 << | Phase 4 | Recruiting | February 2019 | Poland ... 展开 >> II Dept. of Cardiology in Zabrze Medical University of Silesia Recruiting Zabrze, Upper Silesia, Poland, 41-800 Principal Investigator: Andrzej R Tomasik, MD PhD FESC Sub-Investigator: Beata Bialkowska, MD Sub-Investigator: Wojciech Jachec, MD PhD Sub-Investigator: Celina Wojciechowska, MD PhD Sub-Investigator: Damian Kawecki, MD PhD Sub-Investigator: Katarzyna Wozniak, MD Sub-Investigator: Grzegorz Banasik, MD 收起 << |
NCT01425411 | Hypertension ... 展开 >>Left Ventricular Hypertrophy 收起 << | Phase 4 | Completed | - | Turkey ... 展开 >> Mustafa Kemal University School of Medicine, Department of Cardiology Antioch, Turkey, 31100 收起 << |
NCT01115972 | Healthy Pharm... 展开 >>acokinetics of Valsartan 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> Tokyo, Japan 收起 << |
NCT00657241 | Hypertension | Phase 3 | Completed | - | United States, New York ... 展开 >> Erie County Medical Center Buffalo, New York, United States, 14215 收起 << |
NCT00446524 | Hypertension | Phase 3 | Completed | - | Japan ... 展开 >> Novartis Investigative Site Fukuoka, Japan 收起 << |
NCT01850160 | Hypertension | Phase 3 | Completed | - | Colombia ... 展开 >> Centro de Diagnostico Cardiologico Cartagena, Bolivar, Colombia, 130001 Fundacion Cardiomet Cequin Armenia, Quindio, Colombia, 630001 MedPlus Bogota DC, Colombia, 11001 Ecuador Centro AMCOR Quito, Ecuador, EC170150 Centro Clinico quirurgico Quito, Ecuador, EC170150 Centro médico de hipertensión arterial Quito, Ecuador, EC170150 Clínica DAME Quito, Ecuador, EC170150 Consultorio Edificio Novoa Quito, Ecuador, EC170150 收起 << |
NCT02916160 | Chronic Heart Failure ... 展开 >> Sleep Apnea Syndrome 收起 << | Not Applicable | Recruiting | June 22, 2019 | France ... 展开 >> Centre Hospitalier Universitaire de Montpellier Recruiting Montpellier, France, 34295 Principal Investigator: François Roubille, MD, PhD Sub-Investigator: Kamila Solecki, MD Sub-Investigator: Jean Pierre Mallet, MD Sub-Investigator: Dany Jaffuel, MD CHU Nimes Recruiting Nimes, France, 30029 Sub-Investigator: Jean Etienne Ricci, MD Sub-Investigator: Patrice Ray, MD Clinique Pasteur Recruiting Toulouse, France, 31000 Principal Investigator: Atul Pathak, MD, PhD 收起 << |
NCT02518451 | Healthy | Not Applicable | Completed | - | Indonesia ... 展开 >> PT Equilab International Jakarta, Indonesia, 12430 收起 << |
NCT03168568 | Heart Failure | Phase 4 | Recruiting | June 30, 2019 | Switzerland ... 展开 >> University Heart Center Zurich Recruiting Zurich, Switzerland, 8091 Contact: Frank Ruschitzka, MD +41442553353 frank.ruschitzka@usz.ch 收起 << |
NCT00931710 | - | Completed | - | - | |
NCT02631031 | Healthy Normotensive Volunteer... 展开 >>s 收起 << | Phase 1 | Completed | - | Egypt ... 展开 >> Ain Shams university Cairo, Egypt, 11566 收起 << |
NCT02815657 | Type 2 Diabetes | Phase 1 | Completed | - | China ... 展开 >> People's Liberation Army General Hospital of Chengdu Military Region Chengdu, China 收起 << |
NCT03535376 | - | Recruiting | October 2026 | Norway ... 展开 >> St. Olavs University Hospital Recruiting Trondheim, Norway Contact: Magnus Strømmen, MSc 收起 << | |
NCT03594825 | Hypertension;Nephropathy | Phase 4 | Not yet recruiting | December 2023 | - |
NCT01912534 | Hypertrophic Cardiomyopathy | Phase 2 | Active, not recruiting | July 2019 | United States, California ... 展开 >> Stanford University Stanford, California, United States, 94305 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University School Medicine Saint Louis, Missouri, United States, 63110 United States, Ohio Cinncinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Canada, Ontario Toronto General Hospital Toronto, Ontario, Canada, M4W3S5 Toronto Sick Kids Toronto, Ontario, Canada, M5G1X8 收起 << |
NCT02690974 | Hearth Failure With Reduced Ej... 展开 >>ection Fraction (HFrEF) 收起 << | Phase 4 | Completed | - | Canada, Alberta ... 展开 >> Novartis Investigative Site Edmonton, Alberta, Canada, T5H 3V9 Canada, British Columbia Novartis Investigative Site New Westminster, British Columbia, Canada, V3L 3W4 Novartis Investigative Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Novartis Investigative Site Winnipeg, Manitoba, Canada, R2H 2A6 Canada, New Brunswick Novartis Investigative Site Moncton, New Brunswick, Canada, E1C 2Z3 Novartis Investigative Site Moncton, New Brunswick, Canada, E1G 1A7 Canada, Newfoundland and Labrador Novartis Investigative Site St. John's, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Ontario Novartis Investigative Site Burlington, Ontario, Canada, L7M 4Y1 Novartis Investigative Site Cambridge, Ontario, Canada, N1R 6V6 Novartis Investigative Site London, Ontario, Canada, N6A 5A5 Novartis Investigative Site Mississauga, Ontario, Canada, L5K 2L3 Novartis Investigative Site Newmarket, Ontario, Canada, L3Y 2P6 Novartis Investigative Site Newmarket, Ontario, Canada, L3Y 8C3 Novartis Investigative Site Ottawa, Ontario, Canada, K1Y 4W7 Novartis Investigative Site Peterborough, Ontario, Canada, K9J 0B2 Novartis Investigative Site Sarnia, Ontario, Canada, N7T 4X3 Novartis Investigative Site Scarborough, Ontario, Canada, M1E 5E9 Novartis Investigative Site Scarborough, Ontario, Canada, M1P 2V5 Novartis Investigative Site Sudbury, Ontario, Canada, P3E 3B8 Novartis Investigative Site Sudbury, Ontario, Canada, P3E 5M9 Novartis Investigative Site Toronto, Ontario, Canada, M6R 1B5 Novartis Investigative Site Waterloo, Ontario, Canada, N2T 0C1 Novartis Investigative Site Weston, Ontario, Canada, M9N 1W4 Canada, Quebec Novartis Investigative Site Greenfield Park, Quebec, Canada, J4V 2G8 Novartis Investigative Site Joliette, Quebec, Canada, J6E 6J2 Novartis Investigative Site Montreal, Quebec, Canada, H1T 3Y7 Novartis Investigative Site St-Jean-sur-Richelieu, Quebec, Canada, J3A 1J2 Novartis Investigative Site Terrebonne, Quebec, Canada, J6V 2H2 Canada Novartis Investigative Site Brossard, Canada, J4Z 2K9 Novartis Investigative Site Hamilton, Canada, L8L 0A9 Novartis Investigative Site Quebec, Canada, GIV 4G5 Novartis Investigative Site St-Lambert, Canada, J4P 2J2 收起 << |
NCT03180593 | Hypertension Complicated ... 展开 >> Hypertrophy, Left Ventricular Blood Pressure 收起 << | Phase 4 | Completed | - | United States, Texas ... 展开 >> Trinity Hypertension & Metabolic Research Institute Carrollton, Texas, United States, 75006 收起 << |
NCT01918709 | Hypertension, Hyperlipidemia | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Clinical Trial Center, Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT03371797 | - | Completed | - | Pakistan ... 展开 >> Medicell Karachi, Sindh, Pakistan, 75290 收起 << | |
NCT02130687 | Type 2 Diabetes Mellitus ... 展开 >> Hypertension 收起 << | Not Applicable | Recruiting | June 2020 | United States, Tennessee ... 展开 >> Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Jessica R Wilson, M.D. jessica.r.wilson@vanderbilt.edu Contact: Scott Hubers, M.D. scott.hubers@vanderbilt.edu Principal Investigator: Nancy J Brown, M.D. Sub-Investigator: Jessica Devin, M.D. Sub-Investigator: Jessica R Wilson, M.D. Sub-Investigator: Claudia E Ramirez, M.D. Sub-Investigator: Scott Hubers, M.D. 收起 << |
NCT01245608 | Cardiovascular Diseases | Phase 3 | Active, not recruiting | September 2018 | Iran, Islamic Republic of ... 展开 >> Golestan Cohort Center Gonbad, Golestan, Iran, Islamic Republic of 收起 << |
NCT00457483 | Primary Hypertension | Phase 4 | Completed | - | Netherlands ... 展开 >> Nijmegen monitoring project coordinated from Nijmegen Nijmegen, Netherlands 收起 << |
NCT00309257 | Alport Syndrome | Phase 2 | Completed | - | Italy ... 展开 >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 收起 << |
NCT03639493 | Healthy Male Subjects | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Korea University Anam Hospital Seoul, Korea, Republic of 收起 << |
NCT02787798 | Heart Failure | Phase 4 | Recruiting | May 2019 | France ... 展开 >> CHU de Toulouse Recruiting Toulouse, France Contact: Michel Galinier, MD galinier.m@chu-toulouse.fr 收起 << |
NCT01823913 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT00407680 | Type 2 Diabetes Mellitus ... 展开 >> Hypertension 收起 << | Phase 4 | Unknown | March 2009 | Japan ... 展开 >> Kitasato University Recruiting 1-15-1 Kitasato Sagamihara, Kanagawa, Japan, 228-8111 Contact: Keiji Tanaka +81-427-8111 ext 8706 keiji@med.kitasato-u.ac.jp Principal Investigator: Keiji Tanaka, Keiji Tanaka 收起 << |
NCT00530595 | Cardiovascular Disease | Not Applicable | Completed | - | - |
NCT02824081 | Major Depressive Episode ... 展开 >> Suicidal Behavior 收起 << | Not Applicable | Unknown | November 2017 | France ... 展开 >> University Hospital Recruiting Montpellier, France, 34295 Contact: Catherine GENTY, MD +33 4 67 99 61 45 75 c-genty@chu-montpellier.fr 收起 << |
NCT00154271 | Hypertension | Phase 4 | Completed | - | - |
NCT02639637 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT02639637 | - | Completed | - | - | |
NCT00130156 | High Blood Pressure | Phase 4 | Completed | - | Taiwan ... 展开 >> National Taiwan University Hospital. Taipei, Taiwan 收起 << |
NCT03738878 | Hypertension | Phase 4 | Recruiting | December 31, 2020 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37205 Contact: Nancy J Brown, MD 615-343-8701 Contact: Dustin Mayfield, RN 615-343-8701 收起 << |
NCT02924727 | Acute Myocardial Infarction | Phase 3 | Recruiting | April 27, 2020 | - |
NCT01652339 | Healthy Male Subjects | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital Busan, Korea, Republic of, 614-735 收起 << |
NCT01692301 | - | Completed | - | - | |
NCT02174328 | Pre-Eclampsia | Phase 3 | Suspended(Halted prematurely d... 展开 >>ue to low recruitment rate.) 收起 << | May 31, 2018 | Spain ... 展开 >> Obstetrics Unit of La Fe University and Politechnic Hospital Valencia, Spain, 46026 收起 << |
NCT03757390 | Healthy Subjects | Phase 1 | Recruiting | December 14, 2018 | Korea, Republic of ... 展开 >> Korea University Anam Hospital Recruiting Seoul, Korea, Republic of 收起 << |
NCT03541109 | Ischemic Heart Disease ... 展开 >> Acute Coronary Syndrome Revascularization 收起 << | Phase 3 | Not yet recruiting | August 2023 | Iran, Islamic Republic of ... 展开 >> Cardiovascular Research Institute Not yet recruiting Isfahan, Iran, Islamic Republic of Contact: Safoora yazdekhasti 00983136115208 sfa.yazdekhasti@gmail.com Sub-Investigator: Nizal Sarrafzadegan, Professor Sub-Investigator: Shervin Gh Hoseini, MD, PhD Sub-Investigator: Hamidreza Roohafza, MD Sub-Investigator: Marjan Mansourian, PhD Sub-Investigator: Jamshid Najafian, MD Sub-Investigator: Alireza Nateghi Nateghi, PhD 收起 << |
NCT01692301 | Hypertension | Phase 2 | Completed | - | - |
NCT03066804 | Heart Failure With Preserved E... 展开 >>jection Fraction 收起 << | Phase 3 | Recruiting | December 4, 2019 | - |
NCT01318395 | Arterial Hypertension | Phase 3 | Completed | - | Germany ... 展开 >> Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Erlangen, Germany, 91054 Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Nürnberg, Germany, 90471 收起 << |
NCT00738972 | Hypertension | Phase 3 | Terminated(Study terminated ea... 展开 >>rly due to sample size, not possible to perform further statistical analysis.) 收起 << | - | - |
NCT00738972 | - | Terminated(Study terminated ea... 展开 >>rly due to sample size, not possible to perform further statistical analysis.) 收起 << | - | - | |
NCT01252238 | - | Terminated(Study sponsor termi... 展开 >>nated study due to AE's reported with valsartan and aliskiren) 收起 << | - | - | |
NCT01917149 | Dilated Cardiomyopathy | Phase 4 | Completed | - | China ... 展开 >> Xijing Hospital, Department of Cardiology Xi'an, China, 710032 收起 << |
NCT01353508 | Hypertension | Phase 2 | Completed | - | Russian Federation ... 展开 >> Novartis Investigative Site Moscow, Russian Federation, 117198 收起 << |
NCT00878969 | Oxidative Stress ... 展开 >> Endothelial Dysfunction 收起 << | Phase 3 | Terminated(insufficient enroll... 展开 >>ment and retention) 收起 << | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT00171444 | Hypertension | Phase 4 | Completed | - | - |
NCT01252238 | Insulin Sensitivity ... 展开 >> Aortic Compliance Diastolic Function 收起 << | Not Applicable | Terminated(Study sponsor termi... 展开 >>nated study due to AE's reported with valsartan and aliskiren) 收起 << | - | United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 收起 << |
NCT01353508 | - | Completed | - | - | |
NCT00878969 | - | Terminated(insufficient enroll... 展开 >>ment and retention) 收起 << | - | - | |
NCT03657472 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT01030458 | Blood Pressure | Phase 4 | Completed | - | Cameroon ... 展开 >> Ecole de Médecine de Douala Douala, Cameroon Hôpital Général de Yaoundé Yaoundé, Cameroon, BP 5408 Côte D'Ivoire Institut de Cardiologie d'Abidjan Abidjan, Côte D'Ivoire, BP V 206 Gabon Hôpital Central Universitaire de Libreville Libreville, Gabon, BP 4908 Nigeria University of Enugu Enugu, Nigeria University of Ilorin Ilorin, Nigeria, PMB 1515 Senegal Hôpital Aristide Le Dantec Dakar, Senegal 收起 << |
NCT03009474 | Hypertension ... 展开 >>Hyperlipidemias 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Korea University Anam Hospital Seoul, Korea, Republic of 收起 << |
NCT02572960 | Osteoporosis ... 展开 >>Vitamin D Deficiency Cardiovascular Disease 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Endocrinology and Internal Medicine Aarhus, Denmark, 8000 收起 << |
NCT01030458 | - | Completed | - | - | |
NCT01819779 | Healthy Male Subjects | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Metro Hospital Anyang, Kyung Gi, Korea, Republic of, 430-720 收起 << |
NCT03336099 | Osteoarthritis, Knee ... 展开 >> Pain 收起 << | Not Applicable | Completed | - | France ... 展开 >> Thermes de Vals Les Bains Vals Les Bains, Ardèche, France, 07600 收起 << |
NCT00494715 | Diabetes | Phase 3 | Completed | - | Italy ... 展开 >> Clinical Research Center for Rare Diseases "Aldo e Cele Daccò" Ranica, Bergamo, Italy Hospital "Bolognini" Seriate, Bergamo, Italy Hospital "S.Marta e S.Venera" Acireale, Catania, Italy Hospital " Casa Sollievo della Sofferenza" - Unit of Nephrology San Giovanni Rotondo, Foggia, Italy Hospital "Azienda Ospedaliera Ospedali Riuniti di Bergamo" - Unit of Diabetology Bergamo, Italy Hospital "Vittorio Emanuele-Ferrarotto-Santo Bambino" Catania, Italy IRCCS San Raffaele - Unit of General Medicine Milan, Italy University "Federico II" Napoli, Italy Hospital "Azienda Ospedaliera di Parma" - Unit of Nephrology Parma, Italy Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" - Ambulatory of Ponte San Pietro Ponte San Pietro, Italy Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" Unit of Diabetology and Metabolic Diseases Romano di Lombardia, Italy University - AUSL 1 - Institute of Medical Pathology Sassari, Italy Hospital "G:Mazzini" Teramo, Italy Hospital "Azienda Ospedaliera di Treviglio-Caravaggio"Unit of Diabetology and Metabolic Diseases Treviglio, Italy Slovenia Clinical Department of Endocrinology, Diabetes and Metabolic Diseases University Medical Centre Ljubljana Ljubljana, Slovenia, 1000 收起 << |
NCT00732069 | End Stage Renal Failure on Dia... 展开 >>lysis Complication of Hemodialysis 收起 << | Phase 2 | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37323 收起 << |
NCT00732069 | - | Completed | - | - | |
NCT00367562 | IGA Nephropathy | Phase 4 | Completed | - | Argentina ... 展开 >> Hospital Britanico de Buenos Aires Buenos Aires, Argentina, 1280 收起 << |
NCT03532854 | Healthy Male Volunteers | Phase 1 | Not yet recruiting | September 18, 2018 | Korea, Republic of ... 展开 >> LG chem Not yet recruiting Seoul, Gangseo-Gu, Korea, Republic of, 07795 Contact: Subin Lee 02-6987-4153 leesubin@lgchem.com 收起 << |
NCT00239538 | Hypertension ... 展开 >>Diabetes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | - |
NCT00921570 | Diabetes Hype... 展开 >>rtension Proteinuria 收起 << | Phase 4 | Completed | - | Turkey ... 展开 >> GATA Nephrology Ankara, Turkey, 06108 收起 << |
NCT01904981 | Small Abdominal Aortic Aneurys... 展开 >>m 收起 << | Phase 4 | Unknown | October 2016 | Korea, Republic of ... 展开 >> Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Dong-Hoon Choi, MD 82 2 2228 8449 cdhlyj@yuhs.ac 收起 << |
NCT02060019 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Kyungpook university hospital Deagu, Korea, Republic of 收起 << |
NCT02058823 | Hypoxia Sleep... 展开 >> Apnea Obstructive Sleep Apnea 收起 << | Phase 4 | Unknown | December 2017 | France ... 展开 >> Laboratoire EFCR - Functional Cardio-respiratory Exploration Laboratory La Tronche, Isère, France, 38700 收起 << |
NCT01672476 | Hypertension | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of 收起 << |
NCT03508739 | Diabetes Mellitus, Type 2 ... 展开 >> Pre-diabetic Hypertension Elevated Blood Pressure 收起 << | Phase 3 | Recruiting | June 30, 2020 | United States, Pennsylvania ... 展开 >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Jessica R Wilson, MD, MSCI 收起 << |
NCT00821574 | Hypertension, Dyslypidaemia | Phase 4 | Completed | - | - |
NCT01699490 | Major Depressive Disorder | Phase 4 | Unknown | July 2015 | Taiwan ... 展开 >> Department of Psychiatry, National Cheng-Kung University Hospital Recruiting Tainan, Taiwan, 701 Contact: Po See Chen, M.D., Ph.D. +886-6-2353535 ext 5213 chenps@mail.ncku.edu.tw 收起 << |
NCT01518855 | Hypertension | Phase 4 | Completed | - | Japan ... 展开 >> Sapporo, Hokkaido, Japan, 060-0003 Setagaya-ku, Tokyo, Japan, 158-0097 Shinjuku-ku, Tokyo, Japan, 163-6003 Hiroshima, Japan, 733-0011 收起 << |
NCT00338936 | Hypertension | Phase 3 | Completed | - | - |
NCT03432468 | Hypertension | Not Applicable | Not yet recruiting | August 1, 2019 | - |
NCT00202618 | Hypertension ... 展开 >>Diabetes Mellitus Albuminuria 收起 << | Phase 4 | Unknown | - | Japan ... 展开 >> Shiga University of Medical Science Recruiting Otsu, Shiga, Japan, 520-2192 Contact: Atsunori Kashiwagi, Professor 81-77-548-2221 kasiwagi@belle.shiga-med.ac.jp Contact: Hiroshi Maegawa, A. Professor 81-77-548-2222 maegawa@belle.shiga-med.ac.jp Principal Investigator: Hiroshi Maegawa Principal Investigator: Yasuo Kida Principal Investigator: Shu Yamada Principal Investigator: Masataka Nishimura Principal Investigator: Tetsuro Arimura Principal Investigator: Noriko Takahara Principal Investigator: Katsuya Egawa Principal Investigator: Masanori Iwanishi Principal Investigator: Toshiki Fujita Principal Investigator: Aya Kadota 收起 << |
NCT03648333 | Healthy Male Subjects | Phase 1 | Completed | - | - |
NCT02765594 | Primary IgA Nephropathy | Phase 4 | Recruiting | June 2019 | China ... 展开 >> Peing Union Medical College Hospital Recruiting Beijing, China, 100730 Contact: Ruitong Gao, MD 86-010-69155058 gaoruitong@gmail.com 收起 << |
NCT00219180 | Hypertension | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany 收起 << |
NCT02433119 | Hypertension | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Gachon University Gil Hospital Incheon, Korea, Republic of 收起 << |
NCT00409487 | Hypertension, ... 展开 >> Obstructive Sleep Apnea 收起 << | Phase 4 | Completed | - | France ... 展开 >> University Hospital Grenoble Grenoble, France, 38000 收起 << |
NCT00219102 | Hypertension ... 展开 >>Diabetes 收起 << | Phase 3 | Completed | - | United States, North Carolina ... 展开 >> Investigative Site Salisbury,, North Carolina, United States, 28144 Belgium Investigative Site Kortrijk, Belgium Romania Investigative Site Bucharest, Romania Spain Investigative Site Madrid, Spain Sweden Investigative Site Stockholm, Sweden Switzerland Novartis Pharmaceuticals Basel, Switzerland Ukraine Investigative Site Kiev, Ukraine 收起 << |
NCT00089518 | HIV Infections ... 展开 >> Kidney Disease 收起 << | Phase 3 | Withdrawn | - | United States, Indiana ... 展开 >> Indiana University Hospital Indianapolis, Indiana, United States, 46202-5250 Methodist Hospital of Indiana Indianapolis, Indiana, United States, 46202-5250 Wishard Hospital Indianapolis, Indiana, United States, 46202 United States, Missouri Washington University (St. Louis) St. Louis, Missouri, United States, 63108-2138 United States, New York NYU/Bellevue New York, New York, United States, 10016-6481 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio MetroHealth Medical Center Cleveland, Ohio, United States, 44109-1998 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02906 Stanley Street Treatment and Resource Providence, Rhode Island, United States, 02906 The Miriam Hospital Providence, Rhode Island, United States, 02906 收起 << |
NCT00721773 | Renal Function Disorder | Not Applicable | Completed | - | China, Guangdong ... 展开 >> The 1st Affiliated Hospital, Sun Yet-sen University GuangZhou, Guangdong, China, 510080 收起 << |
NCT00311740 | Hypertension | Phase 3 | Completed | - | Japan ... 展开 >> Novartis Pharmaceuticals Tokyo, Japan 收起 << |
NCT00627991 | Cerebrovascular Accident | Not Applicable | Withdrawn | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT00922441 | Essential Hypertension | Phase 2 | Completed | - | - |
NCT03415906 | Heart Failure | Phase 2 | Withdrawn(Difficulties in recr... 展开 >>uiting patients) 收起 << | - | Germany ... 展开 >> Clinical Research Center Hannover, Hannover Medical School Hannover, Germany, 30625 收起 << |
NCT00922441 | - | Completed | - | - | |
NCT03536598 | Hypertension With Hyperlipidem... 展开 >>ia 收起 << | Phase 3 | Completed | - | - |
NCT00732966 | Hypertension | Not Applicable | Unknown | - | - |
NCT02636283 | Peripheral Arterial Disease | Phase 2 | Recruiting | July 2019 | United States, Minnesota ... 展开 >> University of Minnesota Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00168779 | Hypertension | Phase 4 | Completed | - | - |
NCT00240448 | Hypertension | Phase 4 | Completed | - | - |
NCT02687932 | Mitral Valve Insufficiency ... 展开 >> Left Ventricular Dysfunction 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Inha University Hospital Incheon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 Samsung Medical Center Seoul, Korea, Republic of Yonsei University Medical Center Seoul, Korea, Republic of 收起 << |
NCT00549770 | Hypertension | Phase 2 | Completed | - | - |
NCT00394823 | Hypertension | Phase 3 | Completed | - | Germany ... 展开 >> Investigative Centers, Germany Switzerland Novartis Basel, Switzerland 收起 << |
NCT00500604 | Hypertension | Phase 4 | Completed | - | Egypt ... 展开 >> Sanofi-Aventis Administrative Office Cairo, Egypt Hong Kong Sanofi-Aventis Administrative Office Hong Kong, Hong Kong India Sanofi-Aventis Administrative Office Mumbai, India Indonesia Sanofi-Aventis Administrative Office Jakarta, Indonesia Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Malaysia Sanofi-Aventis Administrative Office Kuala Lumpur, Malaysia Morocco Sanofi-Aventis Administrative Office Casablanca, Morocco Pakistan Sanofi-Aventis Administrative Office Karachi, Pakistan Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Singapore Sanofi-Aventis Administrative Office Singapore, Singapore Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan Thailand Sanofi-Aventis Administrative Office Bangkok, Thailand Tunisia Sanofi-Aventis Administrative Office Megrine, Tunisia Vietnam Sanofi-Aventis Administrative Office Ho Chi Minh City, Vietnam 收起 << |
NCT00549770 | - | Completed | - | - | |
NCT00503152 | Diabetes | Phase 3 | Completed | - | Italy ... 展开 >> Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" - Diabetologic Ambulatory of Ponte San Pietro Ponte San Pietro, Bergamo, Italy Clinical Research Center for Rare Diseases "Aldo e Cele Daccò" Ranica, Bergamo, Italy Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" Unit of Diabetology and Metabolic Diseases Romano di Lombardia, Bergamo, Italy Hospital "Bolognini" Seriate, Bergamo, Italy Hospital "Azienda Ospedaliera di Treviglio-Caravaggio"Unit of Diabetology and Metabolic Diseases Treviglio, Bergamo, Italy Hospital "Casa Sollievo della Sofferenza" - Division of Endocrinology San Giovanni Rotondo, Foggia, Italy Hospital "Azienda Ospedaliera Ospedali Riuniti di Bergamo" - Unit of Diabetology Bergamo, Italy IRCCS San Raffaele - Unit of General Medicine Milano, Italy Azienda USL 2 Olbia, Italy 收起 << |
NCT00351130 | Hypertension | Phase 4 | Completed | - | Germany ... 展开 >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland 收起 << |
NCT03553810 | Hypertensive Heart Disease | Phase 3 | Not yet recruiting | December 31, 2021 | Singapore ... 展开 >> National Heart Centre Singapore Not yet recruiting Singapore, Singapore, 169609 Contact: Calvin WL Chin, MD, PhD Principal Investigator: Calvin WL Chin, MD, PhD 收起 << |
NCT02495324 | Essential,Hypertension | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> The Catholic University of Korea, Seoul St.Mary's Hospital Seoul, Banpo-dong, Seocho-gu, Korea, Republic of, 137-701 The Catholic University of Korea, Incheon St.Mary's Hospital Incheon, Bupyeong-gu, Korea, Republic of, 403-720 The Catholic University of Korea, St. Paul's Hospital Seoul, Dongdaemun-gu, Korea, Republic of, 130-709 The Catholic University of Korea, St.Vincent's Hospital. Suwon-si, Gyeonggi-do, Korea, Republic of, 442-723 The Catholic University of Korea,Uijeongbu St.Mary's Hospital Uijeongbu, Gyeonggi-do, Korea, Republic of, 480-717 The Catholic University of Korea, Daejeon St. Mary's Hospital Daejeon, Jung-gu/Daeheung-ro, Korea, Republic of, 301-723 The Catholic University of Korea, Bucheon St.Mary's Hospital Bucheon, Kyunggi-Do, Korea, Republic of, 420-717 The Catholic University of Korea,Yeouido St.Mary's Hospital Seoul, Yeongdeungpo-gu, Korea, Republic of, 150-713 收起 << |
NCT00171782 | HYPERTENSION | Phase 4 | Completed | - | - |
NCT00171132 | Hypertension | Phase 4 | Completed | - | Germany ... 展开 >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland 收起 << |
NCT00129233 | Hypertension ... 展开 >>Type 2 Diabetes Mellitus 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Department of Cardiology, Nagoya University Graduate School of Medicine Nagoya, Aichi, Japan, 466-8550 收起 << |
NCT01071122 | Hypertension | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Goyang-si, Gyeonggido, Korea, Republic of, 411-706 Goyang, Gyeonggido, Korea, Republic of, 410-773 Chungchungbuk-do, Korea, Korea, Republic of, 361-711 Seoul, Korea, Korea, Republic of, 135-720 Seoul, Seoul Teugbyeolsi, Korea, Republic of, 152-703 Busan, Korea, Republic of Gwangju, Korea, Republic of, 501-757 Joong-gu, Korea, Republic of, 100-380 Kungki-do, Korea, Republic of, 463-707 Seoul, Korea, Republic of, 110-744 Seoul, Korea, Republic of, 120-752 Seoul, Korea, Republic of, 135-710 Seoul, Korea, Republic of, 136-705 Seoul, Korea, Republic of, 137-701 Suwan, Korea, Republic of, 443-721 收起 << |
NCT00219193 | Hypertension | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany 收起 << |
NCT00151229 | Aged Systolic... 展开 >> Hypertension 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> VALISH Data Center ING Corporation, 8-21, Shinjuku-ku, Tokyo, Japan, 162-0067 收起 << |
NCT03639480 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 3 | Enrolling by invitation | October 2018 | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of 收起 << |
NCT00250562 | Hypertension | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 收起 << |
NCT00185055 | Healthy | Phase 4 | Completed | - | - |
NCT02606279 | HIV Aging ... 展开 >> Sarcopenia Angiotensin Receptor Antagonists 收起 << | Not Applicable | Terminated(Change in study des... 展开 >>ign and inability to recruit participants) 收起 << | - | United States, North Carolina ... 展开 >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 收起 << |
NCT02606279 | - | Terminated(Change in study des... 展开 >>ign and inability to recruit participants) 收起 << | - | - | |
NCT00171535 | Hypertension | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 收起 << |
NCT00170989 | Hypertension | Phase 3 | Completed | - | Germany ... 展开 >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland 收起 << |
NCT00327587 | Hypertension | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Novartis Pharmaceuticals Corporation E. Hanover, New Jersey, United States, 07936 收起 << |
NCT01400256 | Stroke, Acute | Phase 4 | Withdrawn(lack of recruitment/... 展开 >>patient population) 收起 << | - | United States, California ... 展开 >> Stanford University Medical Center Stanford, California, United States, 94304 收起 << |
NCT01819220 | Hypertension | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Yonsei universty medical center Seoul, Korea, Republic of, 120-752 收起 << |
NCT00241150 | Hypertension ... 展开 >>Metabolic Syndrome 收起 << | Phase 4 | Completed | - | - |
NCT00308425 | De Novo Renal Transplantation | Phase 3 | Completed | - | - |
NCT01508026 | Stage 1 Hypertension ... 展开 >> Stage 2 Hypertension 收起 << | Phase 3 | Completed | - | - |
NCT01281306 | Systolic Hypertension | Phase 2 | Completed | - | - |
NCT00696436 | Hypertension | Phase 3 | Completed | - | - |
NCT01281306 | - | Completed | - | - | |
NCT00518219 | Membranous Nephropathy | Phase 4 | Completed | - | China, Jiangsu ... 展开 >> Research Institute of Nephrology Nanjing, Jiangsu, China, 210002 收起 << |
NCT03012763 | Pharmacokinetics ... 展开 >> Magnetic Resonance Imaging Administration, Oral 收起 << | Phase 1 | Completed | - | - |
NCT02874794 | Heart Failure and Reduced Ejec... 展开 >>tion Fraction 收起 << | Phase 4 | Recruiting | March 7, 2019 | - |
NCT00327145 | Hypertension | Phase 3 | Completed | - | Switzerland ... 展开 >> Novartis Pharmaceuticals Basel, Switzerland 收起 << |
NCT00696436 | - | Completed | - | - | |
NCT02996552 | Tricuspid Disease ... 展开 >> Mitral Regurgitation 收起 << | Not Applicable | Recruiting | June 2021 | Italy ... 展开 >> Istituto Clinico Humanitas Recruiting Rozzano, Milano, Italy, 20089 Contact: Lucia Torracca, MD 00390282244330 lucia.torracca@humanitas.it Principal Investigator: Lucia Torracca, MD Sub-Investigator: Andrea Fumero, MD IRCCS Ospedale San Raffaele Recruiting Milan, Italy, 20132 Contact: Michele De Bonis, MD 00390226437118 debonis.michele@hsr.it Principal Investigator: Michele De Bonis, MD,FESC,FAHA Sub-Investigator: Cinzia Trumello, MD Sub-Investigator: Teodora Nisi, MD Sub-Investigator: Elisabetta Lapenna, MD Sub-Investigator: Ottavio Alfieri, MD Poland Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland Recruiting Warsaw, Poland, 02-507 Contact: Piotr Suwalski, MD 0048225081260 suwalski.piotr@gmail.com Principal Investigator: Piotr Suwalski, MD 收起 << |
NCT02923921 | Pancreatic Cancer | Phase 3 | Recruiting | March 31, 2020 | - |
NCT00399269 | Anemia | Phase 3 | Completed | - | India ... 展开 >> Dr. Shishir Gang Nadiad, Gujarat, India 收起 << |
NCT00297973 | Hypertension | Phase 4 | Completed | - | - |
NCT00804167 | - | Completed | - | - | |
NCT01078688 | - | Completed | - | - | |
NCT01258114 | Overweight Ob... 展开 >>esity 收起 << | Phase 3 | Completed | - | France ... 展开 >> Cabinet Médical Brides les bains, France, 73000 Cabinet Medical Capvern les bains, France, 65000 Cabinet Medical Vals les bains, France, 07000 Cabinet Medical Vichy, France, 03000 Cabinet Medical Vittel, France, 88000 收起 << |
NCT02694796 | Physical Activity ... 展开 >> Chronic Diseases Obesity Diabetes Rheumatic Diseases Cardiovascular Diseases Breast Cancer Chronic Obstructive Pulmonary Disease 收起 << | Not Applicable | Completed | - | France ... 展开 >> Thermes CHEVALLEY Aix-les-Bains, France, 73100 Centre thermal d'Amélie-les-Bains Amélie-les-Bains, France, 66110 Thermes de Bourbon-Lancy Bourbon Lancy, France, 71140 Thermes de Brides-les-Bains Brides-les-Bains, France, 73573 Caleden Complexe Thermal Chaudes-Aigues, France, 15110 Centre thermal d'Eugénie-les-Bains Eugénie-les-Bains, France, 40320 Thermes du Boulou Le Boulou, France, 66160 Thermes de Vals-les-Bains Vals-les-Bains, France, 07600 Thermes CALLOU Vichy, France, 03200 收起 << |
NCT01055353 | - | Completed | - | - | |
NCT00753636 | - | Completed | - | - | |
NCT01368536 | Hypertension ... 展开 >>Stage 2 Hypertension Diabetes 收起 << | Phase 4 | Terminated(Based on results fr... 展开 >>om an ALTITUDE study interim analysis, testing aliskiren concomitantly with an ACE inhibitor or ARB, in diabetics with renal impairment) 收起 << | - | - |
NCT00753636 | Parkinson's Disease | Phase 2 | Completed | - | United States, Illinois ... 展开 >> 710 N. Lake Shore Dr. Chicago, Illinois, United States, 60610 收起 << |
NCT00833573 | - | Completed | - | - | |
NCT02200822 | Heart Failure (HF) | Phase 4 | Unknown | July 2017 | Belgium ... 展开 >> Ziekenhuis Oost Limburg Recruiting Genk, Limburg, Belgium, 3600 Contact: Petra Nijst, MD 3289761525 nijst.petra@gmail.com Contact: Wilfried Mullens, MD, PhD 3289327110 wilfried.mullens@zol.Be Principal Investigator: Petra Nijst, MD Principal Investigator: Frederik Verbrugge, MD Principal Investigator: Matthias Dupont, MD Principal Investigator: Wilfried Mullens, MD, PhD 收起 << |
NCT01368536 | - | Terminated(Based on results fr... 展开 >>om an ALTITUDE study interim analysis, testing aliskiren concomitantly with an ACE inhibitor or ARB, in diabetics with renal impairment) 收起 << | - | - | |
NCT02817360 | Heart Diseases ... 展开 >> Diabetes Mellitus, Type 2 收起 << | Phase 4 | Recruiting | February 2021 | Austria ... 展开 >> Internistische Ordination Recruiting Mödling, Niederösterreich, Austria, 2340 Contact: Christian Feinböck, MD +43 2236 869 142 office@dr-feinboeck.at Contact: Christiane Feinböck +43 2236 869 142 office@dr-feinboeck.at Sub-Investigator: Egbert Seyfried, MD Principal Investigator: Christian Feinböck, MD Klinischen Abteilung für Endokrinologie und Diabetologie MU Graz Recruiting Graz, Steiermark, Austria, 8036 Contact: Harald Sourij +43-316-385-80363 ha.sourij@medunigraz.at Contact: Michael Zink +43-680-128-5120 m.zink@medunigraz.at Sub-Investigator: Julia Mader, MD Prof Sub-Investigator: Eva Novak, MD Sub-Investigator: Caren Sourij, MD Konventhospital der Barmherzigen Brüder Abteilung für Innere Medizin Recruiting Linz, Upper Austria, Austria, 4021 Contact: Martin Clodi, Prof.Dr. martin.clodi@bblinz.at Principal Investigator: Martin Clodi, Prof.Dr. Sub-Investigator: Michael Resl, Dr. Krankenanstalt Rudolfstiftung, 1. Medizinische Abteilung Recruiting Vienna, Austria, 1030 Contact: Bernhard Ludvik, Prof.Dr. +43 1 711 65 ext 2107 bernhard.ludvik@wienkav.at Principal Investigator: Bernhard Ludvik, Prof.Dr. Sub-Investigator: Eva-Christina Krzizek, Dr. Sub-Investigator: Johanna Brix, Dr. Sub-Investigator: Astrid Feder, Dr. Sub-Investigator: Florian Hoellerl, Dr. Medical University of Vienna Univ.Clinic for Internal Medicine II Department of Cardiology Recruiting Vienna, Austria, 1090 Contact: Martin Huelsmann, Doz.Dr. +43 1 40400 ext 46140 martin.huelsmann@meduniwien.ac.at Principal Investigator: Martin Huelsmann, Doz.Dr. Sub-Investigator: Raphael Wurm, Dr. Univ. Klinik für Innere Medizin III Med. Uni Wien Recruiting Vienna, Austria, 1090 Contact: Anton Luger, Prof.Dr. 00 43 1 40400 ext 43100 anton.luger@meduniwien.ac.at Principal Investigator: Anton Luger, Prof.Dr. Sub-Investigator: Michael Krebs, Prof.Dr. Universitätsklinik für Augenheilkunde und Optometrie Medizinische Universität Wien Recruiting Vienna, Austria, 1090 Contact: Sonja Prager, Dr. +43 1 40400 ext 79470 sonja.prager@meduniwien.ac.at Principal Investigator: Sonja Prager, Dr. Sub-Investigator: Julia Hafner, Dr. Diabetes & Stoffwechselambulanz Gesundheitszentrum Wien Süd Recruiting Vienna, Austria, 1100 Contact: Helmut Brath, OA Dr. +43 1 60122 ext 4264 helmut.brath@wgkk.at Principal Investigator: Helmut Brath, OA Dr. 3. Med. Abtlg., KH Hietzing mit Neurologischem Zentrum Rosenhügel Recruiting Vienna, Austria, 1130 Contact: Rudolf Prager, Prof.Dr. +43 1 80110 ext 2351 rudolf.prager@wienkav.at Principal Investigator: Rudolf Prager, Prof.Dr. Sub-Investigator: Slobodan Peric, Dr. Zentrum für Klinische Studien Recruiting Wien, Austria, 1060 Contact: Ursula Hanusch, MD +43 1 266 21 91 dr.hanusch@dieinternistin.com Contact: Michaela Mauritz +43 1 266 21 91 office@dieinternistin.com Sub-Investigator: Marita Spak, MD Netherlands Maastricht University Medical Center; Dep. Cardiology Recruiting Maastricht, Netherlands, 6202 Contact: Hans-Peter Brunner-La Rocca, MD Prof +31 43-3877097 hp.brunnerlarocca@mumc.nl Contact: Mireille Spanjers +31 43-3877099 m.spanjers@mumc.nl Sub-Investigator: Nick Marks, MD Sub-Investigator: Wouter Robaeys, MD New Zealand Christchurch Heart Institute Recruiting Christchurch, New Zealand, 8140 Contact: Richard Troughton, MD Prof +64 3 364 1063 Richard.Troughton@cdhb.health.nz Contact: Lorraine Skelton +64 3 364 1063 lorraine.skelton@cdhb@health.nz Principal Investigator: Richard Troughton, MD Prof 收起 << |
NCT01569815 | - | Completed | - | - | |
NCT01569815 | Mild and Moderate Renal Impair... 展开 >>ment 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Novartis Investigative Site Neuss, Germany, 41460 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 117292 Serbia Novartis Investigative Site Belgrade, Serbia 收起 << |
NCT00741585 | Essential Hypertension ... 展开 >> Cardiovascular Disease Stroke Chronic Kidney Disease 收起 << | Phase 4 | Completed | - | Spain ... 展开 >> CS Friol Friol, Lugo, Spain, 27220 CS Baiona Baiona, Pontevedra, Spain, 36300 CS Bueu Bueu, Pontevedra, Spain, 36930 CS A Estrada La Estrada, Pontevedra, Spain, 26680 CS A Guarda La Guardia, Pontevedra, Spain, 36780 CS Valmiñor Nigran, Pontevedra, Spain, 36250 CS Panxón Nigrán, Pontevedra, Spain, 36340 CS Tomiño Tomiño, Pontevedra, Spain, 36200 Bioengineering & Chronobilogy Labs., University of Vigo Vigo, Pontevedra, Spain, 36200 Hospital do Meixoeiro Vigo, Pontevedra, Spain, 36200 CS Calle Cuba Vigo, Pontevedra, Spain, 36202 CS A Doblada Vigo, Pontevedra, Spain, 36205 CS Coia Vigo, Pontevedra, Spain, 36209 CS Sardoma Vigo, Pontevedra, Spain, 36214 CS Teis Vigo, Pontevedra, Spain, 36216 CS Vilaboa Vilaboa, Pontevedra, Spain, 36141 CS San Roque Vilagarcía De Arousa, Pontevedra, Spain, 36600 CS Fingoi Lugo, Spain, 27002 Complexo Hospitalario Universitario de Ourense Orense, Spain, 32005 CS Lerez Pontevedra, Spain, 36156 收起 << |
NCT00295542 | Hypertension | Phase 4 | Completed | - | Spain ... 展开 >> Hospital Clinico Universitario Santiago de Compostela, Spain, 15706 收起 << |
NCT00000620 | - | Completed | - | - | |
NCT00000620 | Atherosclerosis ... 展开 >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease 收起 << | Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada 收起 << |
NCT01715584 | Hypertension | Phase 4 | Recruiting | December 31, 2019 | Canada, Ontario ... 展开 >> London Health Sciences Centre - Victoria Campus Recruiting London, Ontario, Canada, N6A 5W9 Contact: Craig J Railton, MD, PhD 519 685 8500 ext 58525 Craig.Railton@lhsc.on.ca Principal Investigator: Craig J Railton, MD, PhD Sub-Investigator: Jonathan Fairbairn, BSc Sub-Investigator: George Nicoloau, MD Sub-Investigator: Robert Gros, PhD Sub-Investigator: Jason Franklin, MD Sub-Investigator: John Yoo, MD Sub-Investigator: Kevin Fung, MD Sub-Investigator: Anthony Nichols, MD Sub-Investigator: Danielle McNeil, MD 收起 << |
NCT00391846 | Heart Failure ... 展开 >> Ventricular Dysfunction, Left 收起 << | Phase 4 | Completed | - | Sweden ... 展开 >> Research Site Alvesta, Sweden Research Site Arvika, Sweden Research Site Bjuv, Sweden Research Site Borensberg, Sweden Research Site Bromma, Sweden Research Site Dalby, Sweden Research Site Eskilstuna, Sweden Research Site Gagnef, Sweden Research Site Goeteborg, Sweden Research Site Hisings Karra, Sweden Research Site Huddinge, Sweden Research Site Huskvarna, Sweden Research Site Joenkoeping, Sweden Research Site Kalmar, Sweden Research Site Kungalv, Sweden Research Site Lerum, Sweden Research Site Lessebo, Sweden Research Site Lidkoping, Sweden Research Site Lilla Edet, Sweden Research Site Linkoeping, Sweden Research Site Ludvika, Sweden Research Site Lyckeby, Sweden Research Site Malmo, Sweden Research Site Moheda, Sweden Research Site Motala, Sweden Research Site Orebro, Sweden Research Site Ostersund, Sweden Research Site Skanor, Sweden Research Site Soderakra, Sweden Research Site Stenungsund, Sweden Research Site Stocksund, Sweden Research Site Timra, Sweden Research Site Uddevalla, Sweden Research Site Ulricehamn, Sweden Research Site Umea, Sweden Research Site Uppsala, Sweden Research Site Vasteras, Sweden Research Site Vastervik, Sweden Research Site Vaxjo, Sweden 收起 << |
NCT00391846 | - | Completed | - | - | |
NCT00661895 | Hypertension | Phase 4 | Completed | - | United States, Nebraska ... 展开 >> Creighton Community Health Center Omaha, Nebraska, United States, 68104 收起 << |
NCT00661895 | - | Completed | - | - | |
NCT01536353 | Hypertension | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of 收起 << |
NCT03506412 | Heart Failure With Preserved E... 展开 >>jection Fraction 收起 << | Phase 4 | Recruiting | April 30, 2019 | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 收起 << |
NCT03436147 | - | Recruiting | February 1, 2020 | Turkey ... 展开 >> Bakirkoy Dr. Sadi Konuk Training and Research Hospital Recruiting Istanbul, Turkey, 34147 Contact: ismail alay 0905462375638 dr_ismailalay@hotmail.com 收起 << | |
NCT00670787 | Hypertension | Phase 3 | Completed | - | Japan ... 展开 >> Department of Medicine and Clinical Science, Kyushu University Fukuoka City, Fukuoka, Japan, 812-8582 收起 << |
NCT01601470 | Mild to Moderate Hypertension | Phase 2 | Completed | - | Germany ... 展开 >> Novartis Investigative Site Berlin, Germany, 14050 收起 << |
NCT01601470 | - | Completed | - | - | |
NCT01271985 | Cardiovascular Diseases | Phase 3 | Unknown | April 2018 | Iran, Islamic Republic of ... 展开 >> Golestan Cohort Study Center Gonbad, Golestan, Iran, Islamic Republic of 收起 << |
NCT00684489 | Hypertension | Not Applicable | Completed | - | - |
NCT03502031 | Renal Insufficiency, Chronic ... 展开 >> Diabetic Nephropathy Type 2 收起 << | Phase 4 | Recruiting | December 2020 | United States, Georgia ... 展开 >> NephroNet Recruiting Buford, Georgia, United States, 30518 Contact: James A Tumlin, MD 770-490-9203 jamestumlinmdnephronet@gmail.com Contact: Julie Moss 404-790-0267 jmoss@nephronet.com 收起 << |
NCT00691314 | Stroke Transi... 展开 >>ent Ischemic Attack Atherosclerosis Stenosis Stents 收起 << | Not Applicable | Completed | - | China, Beijing ... 展开 >> Beijing Tiantan Hospital Beijing, Beijing, China, 100050 Xuanwu Hospital Capital Medical University Beijing, Beijing, China, 100053 Peking Union Medical College Hospital Beijing, Beijing, China, 100730 China, Chongqing Southwest Hospital Chongqing, Chongqing, China, 400038 Daping Hospital Chongqing, Chongqing, China, 400042 China, Jiangsu Nanjing General Hospital of Nanjing Military Command Nanjing, Jiangsu, China, 210002 China, Jilin Jilin University Changchun, Jilin, China, 130021 China, Shanghai Huashan Hospital Fudan University Shanghai, Shanghai, China, 200040 China, Sichuan West China Center of Medical Sciences Chengdu, Sichuan, China, 610041 China, Tianjin The General Hospital Under Tianjin Medical Sciences University Tianjin, Tianjin, China, 300052 收起 << |
NCT00310778 | Healthy | Phase 1 | Completed | - | France ... 展开 >> Centre d'Investigation Clinique 9201 Hôpital Européen Georges Pompidou Paris, France, 75908 Cedex 15 收起 << |
NCT01198496 | Hypertension ... 展开 >>Stroke Blood Pressure 收起 << | Phase 4 | Recruiting | December 2019 | Japan ... 展开 >> Jichi Medical Univercity Recruiting Shimotsuke, Tochigi, Japan, 329-0498 Contact: Kazuyuki Shimada, MD kazuyuki@jichi.ac.jp Principal Investigator: Kazuomi Kario, MD 收起 << |
NCT00664846 | Stroke | Not Applicable | Completed | - | - |
NCT02678312 | Pediatric Heart Failure | Phase 2 Phase 3 | Recruiting | April 21, 2021 | - |
NCT02147704 | Hypertension | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Clinical Trial Center, Dongguk University Ilsan Hospital Goyang, Gyeonggi-do, Korea, Republic of, 440-710 收起 << |
NCT00424801 | Microvascular Angina ... 展开 >> Hypertension 收起 << | Not Applicable | Terminated(Due to recent findi... 展开 >>ngs relating MRI contrast to nephrogenic systemic fibrosis) 收起 << | December 2008 | Denmark ... 展开 >> Aarhus Hospital Aarhus, Denmark, 8000 收起 << |
NCT00961207 | Microalbuminuria ... 展开 >> Macroalbuminuric Diabetic Nephropathy Diabetes Proteinuria Albuminuria 收起 << | Phase 4 | Terminated(Altitude trial whic... 展开 >>h used similar drugs was terminated due to increased ADR.) 收起 << | - | United States, Illinois ... 展开 >> John H Stroger Hospital of Cook County Chicago, Illinois, United States, 60612 收起 << |
NCT03190304 | Heart Failure ... 展开 >> Exercise Tolerance Vasodilation Body Composition Muscle Strength 收起 << | Phase 4 | Recruiting | December 14, 2018 | Brazil ... 展开 >> Marcelo Rodrigues dos Santos Recruiting São Paulo, SP, Brazil, 05403-900 Contact: Antonio P Barreto, PhD +55 11 2661-5043 pereira.barreto@incor.usp.br 收起 << |
NCT02966717 | Renal Insufficiency, Chronic ... 展开 >> Nephrotic Syndrome 收起 << | Phase 2 | Active, not recruiting | October 2021 | China, Guangdong ... 展开 >> Zhujiang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510282 收起 << |
NCT01621633 | Hepatic Impairment | Phase 2 | Completed | - | Germany ... 展开 >> Novartis Investigative Site Grunstadt, Germany, D-67269 收起 << |
NCT01621633 | - | Completed | - | - | |
NCT01776047 | Healthy Male Volunteer | Phase 1 | Completed | - | - |
NCT01805362 | Chronic Kidney Disease | Not Applicable | Unknown | February 2017 | France ... 展开 >> Department of Nephrology, Nice University Hospital Recruiting Nice, France, 06000 Contact: vincent Esnault, MD esnault.v@chu-nice.fr Principal Investigator: Vincent Esnault, MD 收起 << |
NCT03035474 | Heart Failure | Not Applicable | Recruiting | July 2020 | - |
NCT03005184 | Heart Failure NYHA Class I ... 展开 >> Heart Failure NYHA Class II Heart Failure NYHA Class III 收起 << | Phase 2 | Withdrawn(Study is being redes... 展开 >>igned and submitted as a new study.) 收起 << | January 2020 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT01922089 | Heart Failure With Reduced Eje... 展开 >>ction Fraction 收起 << | Phase 2 | Completed | - | - |
NCT01922089 | - | Completed | - | - | |
NCT02966665 | Chronic Obstructive Pulmonary ... 展开 >>Disease Pulmonary Artery Hypertension Heart Failure Hypertension 收起 << | Phase 1 | Recruiting | August 2020 | United States, Utah ... 展开 >> George E Wahlen VA Medical Center Recruiting Salt Lake City, Utah, United States, 84132 Contact: Russell Richardson, Ph.D. 801-582-1565 r.richardson@hsc.utah.edu Contact: Ashley Nelson, MD 801-582-1565 ext 4127 ash.nelson@hsc.utah.edu 收起 << |
NCT01377285 | Chronic Renal Failure | Phase 4 | Unknown | December 2018 | Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Tun-Jun Tsai, M.D.; PhD 00886-2-23123456 ext 63953 tjtsai@ntuh.gov.tw Contact: Yung-Ming Chen, M.D. 00886-2-23123456 ext 65993 chenym@ntuh.gov.tw Principal Investigator: Tun-Jun Tsai, M.D.; PhD 收起 << |
NCT00200694 | Heavy Proteinuria | Phase 4 | Terminated(difficulty in patie... 展开 >>nts's inclusion) 收起 << | - | France ... 展开 >> CHU de Nantes Nantes, France 收起 << |
NCT01870739 | Hypertension | Phase 2 | Completed | - | Germany ... 展开 >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Erlangen, Germany, 91054 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 United Kingdom Novartis Investigative Site Glasgow, Scotland, United Kingdom, G12 8TA 收起 << |
NCT00949351 | Type 2 Diabetes With Nephropat... 展开 >>hy 收起 << | Phase 4 | Unknown | September 2010 | Thailand ... 展开 >> Lerdsin General Hospital Not yet recruiting Bangkok, Thailand, 10500 Contact: Krissanapong Manotham, Dr 662 3539799 ext 2501 kmanotham@hotmail.com Contact: Tanaporn Ratanasuwan, Dr tratanas@hotmail.com Principal Investigator: Krissanapong Manotham, Dr 收起 << |
NCT00518479 | Hypertension ... 展开 >>Left Ventricular Hypertrophy 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> Leeds Teaching Hospital NHS Trust Leeds, Wesst Yorkshire, United Kingdom, LS1 3EX 收起 << |
NCT01870739 | - | Completed | - | - |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!